Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ImmuPharma PLC (GB:IMM)
LSE:IMM
ImmuPharma (IMM) Share Price & Analysis
10 Followers
IMM Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.82p - 3.00p
Previous Close2.15p
Volume1.86M
Average Volume (3M)1.36M
Market Cap
£8.95M
Enterprise Value8.29M
Total Cash (Recent Filing)£667.81K
Total Debt (Recent Filing)£111.00
Price to Earnings (P/E)―
Beta2.06
Next Earnings
Sep 25, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding333,403,115
10 Day Avg. Volume1,063,425
30 Day Avg. Volume1,361,362
Standard Deviation0.28
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)5.81
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ImmuPharma News
PremiumCompany Announcements
ImmuPharma Gains Full Support at AGM
PremiumCompany Announcements
ImmuPharma Schedules AGM, Shares Annual Report
PremiumCompany Announcements
ImmuPharma Announces Progress and Reduced LossesPremiumCompany Announcements
ImmuPharma Realizes £1.5 Million from Share Sale
PremiumCompany Announcements
ImmuPharma Major Shareholding Shift Noted
PremiumCompany Announcements
ImmuPharma Showcases Potential at BIO-Equity 2024Options Prices
Currently, No data available
---
Ownership Overview
9.20% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
90.80% Public Companies and
Individual Investors
IMM FAQ
What was ImmuPharma PLC’s price range in the past 12 months?
ImmuPharma PLC lowest share price was 0.82p and its highest was 3.00p in the past 12 months.
What is ImmuPharma PLC’s market cap?
Currently, no data Available
When is ImmuPharma PLC’s upcoming earnings report date?
ImmuPharma PLC’s upcoming earnings report date is Sep 25, 2024 which is in 81 days.
How were ImmuPharma PLC’s earnings last quarter?
Currently, no data Available
Is ImmuPharma PLC overvalued?
According to Wall Street analysts ImmuPharma PLC’s price is currently Overvalued.
Does ImmuPharma PLC pay dividends?
ImmuPharma PLC does not currently pay dividends.
What is ImmuPharma PLC’s EPS estimate?
ImmuPharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ImmuPharma PLC have?
ImmuPharma PLC has 416,437,260 shares outstanding.
What happened to ImmuPharma PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ImmuPharma PLC?
Currently, no hedge funds are holding shares in GB:IMM
---
ImmuPharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
ImmuPharma PLC
ImmuPharma PLC is a drug discovery and development company. The company is focused on the development of drugs based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. It has drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the company's drug candidate and is a treatment for lupus, and life-threatening autoimmune disease. The company's pipeline includes novel peptide-based therapeutics within four therapy areas: Autoimmunity; Anti-Infectives; Metabolism and Cancer.
---
Technical Analysis
---